MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./270/0.1/21.03.25 Share Price

Warrant

DE000MG0Y1K5

Real-time Bid/Ask 05:00:00 26/06/2024 pm IST
0.74 EUR / 0.83 EUR +0.64% Intraday chart for MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./270/0.1/21.03.25
Current month+39.29%
1 month+41.82%
Date Price Change
26/24/26 0.74 -5.13%
25/24/25 0.78 +5.41%
24/24/24 0.74 -9.76%
21/24/21 0.82 0.00%
20/24/20 0.82 +22.39%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 04:47 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG0Y1K
ISINDE000MG0Y1K5
Date issued 27/03/2024
Strike 270 $
Maturity 21/03/2025 (268 Days)
Parity 10 : 1
Emission price 1.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.46
Lowest since issue 0.43
Spread 0.09
Spread %10.84%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.9 USD
Average target price
279.2 USD
Spread / Average Target
+19.38%
Consensus